Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Neuro-Oncology|February 11, 2004
Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium studyJohn J Laterra, Stuart A Grossman, Kathryn A Carson, et al.
Frontiers in Oncology|April 3, 2023
<i>In-vivo</i> magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disordersDavid O Kamson, Viveka Chinnasamy, Stuart A Grossman, et al.
Journal of Neuro-Oncology|August 30, 2012
Use of personalized molecular biomarkers in the clinical care of adults with glioblastomasMatthias Holdhoff, Xiaobu Ye, Jaishri O Blakeley, et al.
Cancer Investigation|March 16, 2019
Aquaporin-4 Expression Patterns in Glioblastoma Pre-Chemoradiation and at Time of Suspected ProgressionMichael Levy, Scott Barletta, Hwa Huang, et al.
Neuro-Oncology Practice|April 8, 2020
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncologySurabhi Ranjan, Nebojša Skorupan, Xiaobu Ye, et al.
Neuro-Oncology|July 29, 2004
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literatureMary Y Armanios, Stuart A Grossman, Stephen C Yang, et al.
Cancer Investigation|July 15, 2014
Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomasRyan P Lange, Allen Everett, Pratima Dulloor, et al.
Neuro-Oncology|May 15, 2008
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant gliomaSurasak Phuphanich, Kathryn A Carson, Stuart A Grossman, et al.
Journal of Neuro-Oncology|March 19, 2017
The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot studySadhana Jackson, Richard T George, Martin A Lodge, et al.
Neuro-Oncology|August 2, 2005
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaSteven Brem, Stuart A Grossman, Kathryn A Carson, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Neuro-Oncology|February 11, 2004
Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium studyJohn J Laterra, Stuart A Grossman, Kathryn A Carson, et al.
Frontiers in Oncology|April 3, 2023
<i>In-vivo</i> magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disordersDavid O Kamson, Viveka Chinnasamy, Stuart A Grossman, et al.
Journal of Neuro-Oncology|August 30, 2012
Use of personalized molecular biomarkers in the clinical care of adults with glioblastomasMatthias Holdhoff, Xiaobu Ye, Jaishri O Blakeley, et al.
Cancer Investigation|March 16, 2019
Aquaporin-4 Expression Patterns in Glioblastoma Pre-Chemoradiation and at Time of Suspected ProgressionMichael Levy, Scott Barletta, Hwa Huang, et al.
Neuro-Oncology Practice|April 8, 2020
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncologySurabhi Ranjan, Nebojša Skorupan, Xiaobu Ye, et al.
Neuro-Oncology|July 29, 2004
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literatureMary Y Armanios, Stuart A Grossman, Stephen C Yang, et al.
Cancer Investigation|July 15, 2014
Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomasRyan P Lange, Allen Everett, Pratima Dulloor, et al.
Neuro-Oncology|May 15, 2008
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant gliomaSurasak Phuphanich, Kathryn A Carson, Stuart A Grossman, et al.
Journal of Neuro-Oncology|March 19, 2017
The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot studySadhana Jackson, Richard T George, Martin A Lodge, et al.
Neuro-Oncology|August 2, 2005
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaSteven Brem, Stuart A Grossman, Kathryn A Carson, et al.
Pageof 18